Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-27

Clinical Trial Update: Primary Chemoprevention of Familial Adenomatous Polyposis With Berberine Hydrochloride [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update on berberine hydrochloride for primary chemoprevention in individuals with familial adenomatous polyposis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Berberine hydrochloride (berberine hydrochloride)

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Colorectal Adenomas | Phase 2, Phase 3 | Status: COMPLETED